Expression of JAK1/2 and STAT3 in latently infected cells from both lines was suggestive of an IL-6 response axis (IL6(R)/JAK/STAT3) known to be activated in hematologic malignancies [149]. This evidence concerns the gene JAK1 and hematologic disorder.